HEADER LIGASE 23-JUN-23 8PJN TITLE CATALYTIC MODULE OF HUMAN CTLH E3 LIGASE BOUND TO MULTIPHOSPHORYLATED TITLE 2 UBE2H~UBIQUITIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN TRANSFERASE RMND5A; COMPND 3 CHAIN: b; COMPND 4 SYNONYM: P44CTLH,PROTEIN RMD5 HOMOLOG A; COMPND 5 EC: 2.3.2.27; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: UBIQUITIN-CONJUGATING ENZYME E2 H; COMPND 9 CHAIN: 2; COMPND 10 SYNONYM: (E3-INDEPENDENT) E2 UBIQUITIN-CONJUGATING ENZYME H,E2 COMPND 11 UBIQUITIN-CONJUGATING ENZYME H,UBCH2,UBIQUITIN CARRIER PROTEIN H, COMPND 12 UBIQUITIN-CONJUGATING ENZYME E2-20K,UBIQUITIN-PROTEIN LIGASE H; COMPND 13 EC: 2.3.2.23,2.3.2.24; COMPND 14 ENGINEERED: YES; COMPND 15 MUTATION: YES; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: E3 UBIQUITIN-PROTEIN TRANSFERASE MAEA; COMPND 18 CHAIN: i; COMPND 19 SYNONYM: CELL PROLIFERATION-INDUCING GENE 5 PROTEIN,ERYTHROBLAST COMPND 20 MACROPHAGE PROTEIN,HUMAN LUNG CANCER ONCOGENE 10 PROTEIN,HLC-10, COMPND 21 MACROPHAGE ERYTHROBLAST ATTACHER,P44EMLP; COMPND 22 EC: 2.3.2.27; COMPND 23 ENGINEERED: YES; COMPND 24 MOL_ID: 4; COMPND 25 MOLECULE: UBIQUITIN; COMPND 26 CHAIN: u; COMPND 27 SYNONYM: POLYUBIQUITIN-C; COMPND 28 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RMND5A; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: UBE2H; SOURCE 13 EXPRESSION_SYSTEM: TRICHOPLUSIA; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7110; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: MAEA, EMP, HLC10, PIG5; SOURCE 20 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 22 MOL_ID: 4; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 GENE: UBC; SOURCE 27 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 28 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS E3 UBIQUITIN LIGASE, E2 UBIQUITIN-CONJUGATING ENZYME, KEYWDS 2 PHOSPHORYLATION, CTLH, GID, UBE2H, LIGASE EXPDTA ELECTRON MICROSCOPY AUTHOR J.CHRUSTOWICZ,D.SHERPA,R.J.PRABU,B.A.SCHULMAN REVDAT 3 31-JAN-24 8PJN 1 JRNL REVDAT 2 24-JAN-24 8PJN 1 HELIX SHEET REVDAT 1 03-JAN-24 8PJN 0 JRNL AUTH J.CHRUSTOWICZ,D.SHERPA,J.LI,C.R.LANGLOIS,E.C.PAPADOPOULOU, JRNL AUTH 2 D.T.VU,L.A.HEHL,O.KARAYEL,V.BEIER,S.VON GRONAU,J.MULLER, JRNL AUTH 3 J.R.PRABU,M.MANN,G.KLEIGER,A.F.ALPI,B.A.SCHULMAN JRNL TITL MULTISITE PHOSPHORYLATION DICTATES SELECTIVE E2-E3 PAIRING JRNL TITL 2 AS REVEALED BY UBC8/UBE2H-GID/CTLH ASSEMBLIES. JRNL REF MOL.CELL V. 84 293 2024 JRNL REFN ISSN 1097-2765 JRNL PMID 38113892 JRNL DOI 10.1016/J.MOLCEL.2023.11.027 REMARK 2 REMARK 2 RESOLUTION. 3.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.400 REMARK 3 NUMBER OF PARTICLES : 45472 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8PJN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1292131461. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : COMPLEX OF HUMAN CTLHSR4 E3 REMARK 245 LIGASE BOUND TO ENGINEERED REMARK 245 ARMC8-SPECIFIC VH AND REMARK 245 MULTIPHOSPHORYLATED UBE2H~ REMARK 245 UBIQUITIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : MAP OBTAINED BY FOCUS REMARK 245 REFINEMENT OVER THE CATALYTIC MODULE (RMND5A, MAEA) AND UBE2H~ REMARK 245 UBIQUITIN REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2300.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6800.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: b, 2, i, u REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL b 166 REMARK 465 ARG b 167 REMARK 465 VAL b 168 REMARK 465 LEU b 169 REMARK 465 ARG b 170 REMARK 465 PRO b 171 REMARK 465 ALA b 172 REMARK 465 LEU b 173 REMARK 465 GLU b 174 REMARK 465 TRP b 175 REMARK 465 ALA b 176 REMARK 465 VAL b 177 REMARK 465 SER b 178 REMARK 465 ASN b 179 REMARK 465 ARG b 180 REMARK 465 GLU b 181 REMARK 465 MET b 182 REMARK 465 LEU b 183 REMARK 465 ILE b 184 REMARK 465 ALA b 185 REMARK 465 GLN b 186 REMARK 465 ASN b 187 REMARK 465 SER b 188 REMARK 465 SER b 189 REMARK 465 LEU b 190 REMARK 465 GLU b 191 REMARK 465 PHE b 192 REMARK 465 LYS b 193 REMARK 465 LEU b 194 REMARK 465 HIS b 195 REMARK 465 ARG b 196 REMARK 465 LEU b 197 REMARK 465 TYR b 198 REMARK 465 PHE b 199 REMARK 465 ILE b 200 REMARK 465 SER b 201 REMARK 465 LEU b 202 REMARK 465 LEU b 203 REMARK 465 MET b 204 REMARK 465 GLY b 205 REMARK 465 GLY b 206 REMARK 465 THR b 207 REMARK 465 THR b 208 REMARK 465 ASN b 209 REMARK 465 GLN b 210 REMARK 465 ARG b 211 REMARK 465 GLU b 212 REMARK 465 ALA b 213 REMARK 465 LEU b 214 REMARK 465 GLN b 215 REMARK 465 TYR b 216 REMARK 465 ALA b 217 REMARK 465 LYS b 218 REMARK 465 ASN b 219 REMARK 465 PHE b 220 REMARK 465 GLN b 221 REMARK 465 PRO b 222 REMARK 465 PHE b 223 REMARK 465 ALA b 224 REMARK 465 LEU b 225 REMARK 465 ASN b 226 REMARK 465 HIS b 227 REMARK 465 GLN b 228 REMARK 465 LYS b 229 REMARK 465 ASP b 230 REMARK 465 ILE b 231 REMARK 465 GLN b 232 REMARK 465 VAL b 233 REMARK 465 LEU b 234 REMARK 465 MET b 235 REMARK 465 GLY b 236 REMARK 465 SER b 237 REMARK 465 LEU b 238 REMARK 465 VAL b 239 REMARK 465 TYR b 240 REMARK 465 LEU b 241 REMARK 465 ARG b 242 REMARK 465 GLN b 243 REMARK 465 GLY b 244 REMARK 465 ILE b 245 REMARK 465 GLU b 246 REMARK 465 ASN b 247 REMARK 465 SER b 248 REMARK 465 PRO b 249 REMARK 465 TYR b 250 REMARK 465 VAL b 251 REMARK 465 HIS b 252 REMARK 465 LEU b 253 REMARK 465 LEU b 254 REMARK 465 ASP b 255 REMARK 465 ALA b 256 REMARK 465 ASN b 257 REMARK 465 GLN b 258 REMARK 465 TRP b 259 REMARK 465 ALA b 260 REMARK 465 MET 2 1 REMARK 465 SER 2 2 REMARK 465 SER 2 3 REMARK 465 PRO 2 4 REMARK 465 SER 2 5 REMARK 465 PRO 2 6 REMARK 465 GLU 2 151 REMARK 465 GLU 2 152 REMARK 465 ALA 2 153 REMARK 465 LEU 2 154 REMARK 465 LYS 2 155 REMARK 465 GLU 2 156 REMARK 465 GLN 2 157 REMARK 465 GLU 2 158 REMARK 465 GLU 2 159 REMARK 465 GLY 2 160 REMARK 465 THR 2 161 REMARK 465 GLY 2 162 REMARK 465 ASP 2 163 REMARK 465 ASP 2 176 REMARK 465 GLU 2 177 REMARK 465 ALA 2 178 REMARK 465 GLN 2 179 REMARK 465 ASP 2 180 REMARK 465 MET 2 181 REMARK 465 GLU 2 182 REMARK 465 LEU 2 183 REMARK 465 MET i 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET b 1 CG SD CE REMARK 470 ASP b 2 CG OD1 OD2 REMARK 470 GLU b 26 CG CD OE1 OE2 REMARK 470 GLU b 30 CG CD OE1 OE2 REMARK 470 ASP b 34 CG OD1 OD2 REMARK 470 GLU b 42 CG CD OE1 OE2 REMARK 470 SER b 46 OG REMARK 470 HIS b 47 CG ND1 CD2 CE1 NE2 REMARK 470 GLU b 52 CG CD OE1 OE2 REMARK 470 THR b 56 OG1 CG2 REMARK 470 ASP b 70 CG OD1 OD2 REMARK 470 ASP b 81 CG OD1 OD2 REMARK 470 SER b 103 OG REMARK 470 ILE b 106 CG1 CG2 CD1 REMARK 470 ASP b 107 CG OD1 OD2 REMARK 470 ASP b 113 CG OD1 OD2 REMARK 470 GLN b 115 CG CD OE1 NE2 REMARK 470 GLU b 124 CG CD OE1 OE2 REMARK 470 ASP b 133 CG OD1 OD2 REMARK 470 GLU b 137 CG CD OE1 OE2 REMARK 470 SER b 145 OG REMARK 470 ASP b 147 CG OD1 OD2 REMARK 470 SER b 149 OG REMARK 470 GLN b 150 CG CD OE1 NE2 REMARK 470 GLU b 152 CG CD OE1 OE2 REMARK 470 GLU b 156 CG CD OE1 OE2 REMARK 470 ARG b 159 CG CD NE CZ NH1 NH2 REMARK 470 GLU b 162 CG CD OE1 OE2 REMARK 470 LYS b 165 CG CD CE NZ REMARK 470 ASP b 261 CG OD1 OD2 REMARK 470 ASP b 264 CG OD1 OD2 REMARK 470 ILE b 265 CG1 CG2 CD1 REMARK 470 ARG b 268 CG CD NE CZ NH1 NH2 REMARK 470 GLU b 279 CG CD OE1 OE2 REMARK 470 GLU b 304 CG CD OE1 OE2 REMARK 470 GLN b 307 CG CD OE1 NE2 REMARK 470 THR b 309 OG1 CG2 REMARK 470 ASN b 313 CG OD1 ND2 REMARK 470 LYS b 315 CG CD CE NZ REMARK 470 ASP b 316 CG OD1 OD2 REMARK 470 GLU b 321 CG CD OE1 OE2 REMARK 470 ASP b 323 CG OD1 OD2 REMARK 470 LYS b 326 CG CD CE NZ REMARK 470 LYS b 327 CG CD CE NZ REMARK 470 ASP b 361 CG OD1 OD2 REMARK 470 PHE b 367 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER b 370 OG REMARK 470 LYS b 371 CG CD CE NZ REMARK 470 MET b 379 CG SD CE REMARK 470 GLU b 380 CG CD OE1 OE2 REMARK 470 SER b 382 OG REMARK 470 LYS 2 22 CG CD CE NZ REMARK 470 GLU 2 24 CG CD OE1 OE2 REMARK 470 GLU 2 33 CG CD OE1 OE2 REMARK 470 LYS 2 37 CG CD CE NZ REMARK 470 GLN 2 42 CG CD OE1 NE2 REMARK 470 GLU 2 47 CG CD OE1 OE2 REMARK 470 ASP 2 56 CG OD1 OD2 REMARK 470 ASP 2 59 CG OD1 OD2 REMARK 470 ASP 2 80 CG OD1 OD2 REMARK 470 SER 2 83 OG REMARK 470 ILE 2 119 CG1 CG2 CD1 REMARK 470 ASP 2 120 CG OD1 OD2 REMARK 470 GLU 2 135 CG CD OE1 OE2 REMARK 470 GLU 2 136 CG CD OE1 OE2 REMARK 470 LYS 2 138 CG CD CE NZ REMARK 470 LYS 2 140 CG CD CE NZ REMARK 470 LYS 2 142 CG CD CE NZ REMARK 470 THR 2 150 OG1 CG2 REMARK 470 ASP 2 172 CG OD1 OD2 REMARK 470 GLU 2 175 CG CD OE1 OE2 REMARK 470 LYS i 15 CG CD CE NZ REMARK 470 GLU i 18 CG CD OE1 OE2 REMARK 470 GLU i 53 CG CD OE1 OE2 REMARK 470 ASP i 65 CG OD1 OD2 REMARK 470 ASP i 72 CG OD1 OD2 REMARK 470 GLU i 76 CG CD OE1 OE2 REMARK 470 GLU i 87 CG CD OE1 OE2 REMARK 470 GLU i 94 CG CD OE1 OE2 REMARK 470 ASP i 112 CG OD1 OD2 REMARK 470 GLU i 131 CG CD OE1 OE2 REMARK 470 GLN i 148 CG CD OE1 NE2 REMARK 470 GLU i 152 CG CD OE1 OE2 REMARK 470 GLU i 158 CG CD OE1 OE2 REMARK 470 GLU i 165 CG CD OE1 OE2 REMARK 470 GLU i 171 CG CD OE1 OE2 REMARK 470 GLU i 174 CG CD OE1 OE2 REMARK 470 ARG i 219 CG CD NE CZ NH1 NH2 REMARK 470 SER i 226 OG REMARK 470 GLN i 227 CG CD OE1 NE2 REMARK 470 GLU i 229 CG CD OE1 OE2 REMARK 470 ASP i 234 CG OD1 OD2 REMARK 470 ARG i 237 CG CD NE CZ NH1 NH2 REMARK 470 ASP i 248 CG OD1 OD2 REMARK 470 HIS i 250 CG ND1 CD2 CE1 NE2 REMARK 470 LYS i 255 CG CD CE NZ REMARK 470 ASP i 256 CG OD1 OD2 REMARK 470 LYS i 304 CG CD CE NZ REMARK 470 GLU i 305 CG CD OE1 OE2 REMARK 470 ASP i 306 CG OD1 OD2 REMARK 470 SER i 308 OG REMARK 470 SER i 309 OG REMARK 470 ASP i 345 CG OD1 OD2 REMARK 470 GLU i 349 CG CD OE1 OE2 REMARK 470 SER i 369 OG REMARK 470 GLN i 372 CG CD OE1 NE2 REMARK 470 ASP i 374 CG OD1 OD2 REMARK 470 LYS i 375 CG CD CE NZ REMARK 470 LYS i 382 CG CD CE NZ REMARK 470 GLU i 391 CG CD OE1 OE2 REMARK 470 GLU u 16 CG CD OE1 OE2 REMARK 470 VAL u 17 CG1 CG2 REMARK 470 GLU u 18 CG CD OE1 OE2 REMARK 470 SER u 20 OG REMARK 470 ASP u 21 CG OD1 OD2 REMARK 470 GLU u 24 CG CD OE1 OE2 REMARK 470 ASN u 25 CG OD1 ND2 REMARK 470 ASP u 32 CG OD1 OD2 REMARK 470 GLU u 34 CG CD OE1 OE2 REMARK 470 ASP u 39 CG OD1 OD2 REMARK 470 LYS u 48 CG CD CE NZ REMARK 470 GLU u 51 CG CD OE1 OE2 REMARK 470 THR u 55 OG1 CG2 REMARK 470 LYS u 63 CG CD CE NZ REMARK 470 GLU u 64 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS 2 87 C GLY u 76 1.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU b 52 52.03 -92.27 REMARK 500 SER b 103 54.64 -92.46 REMARK 500 ALA b 112 -37.74 -132.50 REMARK 500 PRO b 294 39.73 -83.16 REMARK 500 ALA b 295 -39.58 -131.20 REMARK 500 CYS b 336 135.66 -38.40 REMARK 500 ASN b 346 -3.41 68.02 REMARK 500 ASN b 347 61.32 -153.82 REMARK 500 LEU b 352 -169.96 -78.35 REMARK 500 SER b 370 -57.61 -137.26 REMARK 500 LYS 2 60 46.84 -106.62 REMARK 500 ASN 2 92 -60.08 -93.91 REMARK 500 PRO 2 118 49.34 -86.39 REMARK 500 PHE 2 173 -179.58 -68.11 REMARK 500 CYS i 61 71.01 51.77 REMARK 500 ASN i 185 56.75 -95.94 REMARK 500 LYS i 193 61.34 62.29 REMARK 500 LEU i 243 4.60 -69.59 REMARK 500 PRO i 247 44.69 -77.03 REMARK 500 ASP i 248 20.30 -142.48 REMARK 500 PRO i 260 47.28 -76.03 REMARK 500 ASP i 373 -113.62 52.90 REMARK 500 LYS i 375 143.29 -172.33 REMARK 500 ASN u 60 60.39 60.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN i 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS b 331 NE2 REMARK 620 2 CYS i 302 SG 101.9 REMARK 620 3 CYS i 314 SG 108.4 111.2 REMARK 620 4 CYS i 317 SG 106.7 106.8 120.3 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN b 501 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS b 354 SG REMARK 620 2 HIS b 356 ND1 102.0 REMARK 620 3 CYS b 374 SG 111.1 108.3 REMARK 620 4 CYS b 377 SG 106.8 106.6 120.4 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-17713 RELATED DB: EMDB REMARK 900 CATALYTIC MODULE OF HUMAN CTLH E3 LIGASE BOUND TO REMARK 900 MULTIPHOSPHORYLATED UBE2H~UBIQUITIN REMARK 900 RELATED ID: EMD-17715 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-17716 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-17764 RELATED DB: EMDB REMARK 900 RELATED ID: 8PMQ RELATED DB: PDB REMARK 900 RELATED ID: EMD-17717 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-17709 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-17710 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-17707 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-17706 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-17705 RELATED DB: EMDB DBREF 8PJN b 1 391 UNP Q9H871 RMD5A_HUMAN 1 391 DBREF 8PJN 2 1 183 UNP P62256 UBE2H_HUMAN 1 183 DBREF 8PJN i 1 396 UNP Q7L5Y9 MAEA_HUMAN 1 396 DBREF 8PJN u 1 76 UNP P0CG48 UBC_HUMAN 1 76 SEQADV 8PJN LYS 2 87 UNP P62256 CYS 87 ENGINEERED MUTATION SEQRES 1 b 391 MET ASP GLN CYS VAL THR VAL GLU ARG GLU LEU GLU LYS SEQRES 2 b 391 VAL LEU HIS LYS PHE SER GLY TYR GLY GLN LEU CYS GLU SEQRES 3 b 391 ARG GLY LEU GLU GLU LEU ILE ASP TYR THR GLY GLY LEU SEQRES 4 b 391 LYS HIS GLU ILE LEU GLN SER HIS GLY GLN ASP ALA GLU SEQRES 5 b 391 LEU SER GLY THR LEU SER LEU VAL LEU THR GLN CYS CYS SEQRES 6 b 391 LYS ARG ILE LYS ASP THR VAL GLN LYS LEU ALA SER ASP SEQRES 7 b 391 HIS LYS ASP ILE HIS SER SER VAL SER ARG VAL GLY LYS SEQRES 8 b 391 ALA ILE ASP LYS ASN PHE ASP SER ASP ILE SER SER VAL SEQRES 9 b 391 GLY ILE ASP GLY CYS TRP GLN ALA ASP SER GLN ARG LEU SEQRES 10 b 391 LEU ASN GLU VAL MET VAL GLU HIS PHE PHE ARG GLN GLY SEQRES 11 b 391 MET LEU ASP VAL ALA GLU GLU LEU CYS GLN GLU SER GLY SEQRES 12 b 391 LEU SER VAL ASP PRO SER GLN LYS GLU PRO PHE VAL GLU SEQRES 13 b 391 LEU ASN ARG ILE LEU GLU ALA LEU LYS VAL ARG VAL LEU SEQRES 14 b 391 ARG PRO ALA LEU GLU TRP ALA VAL SER ASN ARG GLU MET SEQRES 15 b 391 LEU ILE ALA GLN ASN SER SER LEU GLU PHE LYS LEU HIS SEQRES 16 b 391 ARG LEU TYR PHE ILE SER LEU LEU MET GLY GLY THR THR SEQRES 17 b 391 ASN GLN ARG GLU ALA LEU GLN TYR ALA LYS ASN PHE GLN SEQRES 18 b 391 PRO PHE ALA LEU ASN HIS GLN LYS ASP ILE GLN VAL LEU SEQRES 19 b 391 MET GLY SER LEU VAL TYR LEU ARG GLN GLY ILE GLU ASN SEQRES 20 b 391 SER PRO TYR VAL HIS LEU LEU ASP ALA ASN GLN TRP ALA SEQRES 21 b 391 ASP ILE CYS ASP ILE PHE THR ARG ASP ALA CYS ALA LEU SEQRES 22 b 391 LEU GLY LEU SER VAL GLU SER PRO LEU SER VAL SER PHE SEQRES 23 b 391 SER ALA GLY CYS VAL ALA LEU PRO ALA LEU ILE ASN ILE SEQRES 24 b 391 LYS ALA VAL ILE GLU GLN ARG GLN CYS THR GLY VAL TRP SEQRES 25 b 391 ASN GLN LYS ASP GLU LEU PRO ILE GLU VAL ASP LEU GLY SEQRES 26 b 391 LYS LYS CYS TRP TYR HIS SER ILE PHE ALA CYS PRO ILE SEQRES 27 b 391 LEU ARG GLN GLN THR THR ASP ASN ASN PRO PRO MET LYS SEQRES 28 b 391 LEU VAL CYS GLY HIS ILE ILE SER ARG ASP ALA LEU ASN SEQRES 29 b 391 LYS MET PHE ASN GLY SER LYS LEU LYS CYS PRO TYR CYS SEQRES 30 b 391 PRO MET GLU GLN SER PRO GLY ASP ALA LYS GLN ILE PHE SEQRES 31 b 391 PHE SEQRES 1 2 183 MET SER SER PRO SER PRO GLY LYS ARG ARG MET ASP THR SEQRES 2 2 183 ASP VAL VAL LYS LEU ILE GLU SER LYS HIS GLU VAL THR SEQRES 3 2 183 ILE LEU GLY GLY LEU ASN GLU PHE VAL VAL LYS PHE TYR SEQRES 4 2 183 GLY PRO GLN GLY THR PRO TYR GLU GLY GLY VAL TRP LYS SEQRES 5 2 183 VAL ARG VAL ASP LEU PRO ASP LYS TYR PRO PHE LYS SER SEQRES 6 2 183 PRO SER ILE GLY PHE MET ASN LYS ILE PHE HIS PRO ASN SEQRES 7 2 183 ILE ASP GLU ALA SER GLY THR VAL LYS LEU ASP VAL ILE SEQRES 8 2 183 ASN GLN THR TRP THR ALA LEU TYR ASP LEU THR ASN ILE SEQRES 9 2 183 PHE GLU SER PHE LEU PRO GLN LEU LEU ALA TYR PRO ASN SEQRES 10 2 183 PRO ILE ASP PRO LEU ASN GLY ASP ALA ALA ALA MET TYR SEQRES 11 2 183 LEU HIS ARG PRO GLU GLU TYR LYS GLN LYS ILE LYS GLU SEQRES 12 2 183 TYR ILE GLN LYS TYR ALA THR GLU GLU ALA LEU LYS GLU SEQRES 13 2 183 GLN GLU GLU GLY THR GLY ASP SEP SEP SEP GLU SEP SEP SEQRES 14 2 183 MET SEP ASP PHE SEP GLU ASP GLU ALA GLN ASP MET GLU SEQRES 15 2 183 LEU SEQRES 1 i 396 MET ALA VAL GLN GLU SER ALA ALA GLN LEU SER MET THR SEQRES 2 i 396 LEU LYS VAL GLN GLU TYR PRO THR LEU LYS VAL PRO TYR SEQRES 3 i 396 GLU THR LEU ASN LYS ARG PHE ARG ALA ALA GLN LYS ASN SEQRES 4 i 396 ILE ASP ARG GLU THR SER HIS VAL THR MET VAL VAL ALA SEQRES 5 i 396 GLU LEU GLU LYS THR LEU SER GLY CYS PRO ALA VAL ASP SEQRES 6 i 396 SER VAL VAL SER LEU LEU ASP GLY VAL VAL GLU LYS LEU SEQRES 7 i 396 SER VAL LEU LYS ARG LYS ALA VAL GLU SER ILE GLN ALA SEQRES 8 i 396 GLU ASP GLU SER ALA LYS LEU CYS LYS ARG ARG ILE GLU SEQRES 9 i 396 HIS LEU LYS GLU HIS SER SER ASP GLN PRO ALA ALA ALA SEQRES 10 i 396 SER VAL TRP LYS ARG LYS ARG MET ASP ARG MET MET VAL SEQRES 11 i 396 GLU HIS LEU LEU ARG CYS GLY TYR TYR ASN THR ALA VAL SEQRES 12 i 396 LYS LEU ALA ARG GLN SER GLY ILE GLU ASP LEU VAL ASN SEQRES 13 i 396 ILE GLU MET PHE LEU THR ALA LYS GLU VAL GLU GLU SER SEQRES 14 i 396 LEU GLU ARG ARG GLU THR ALA THR CYS LEU ALA TRP CYS SEQRES 15 i 396 HIS ASP ASN LYS SER ARG LEU ARG LYS MET LYS SER CYS SEQRES 16 i 396 LEU GLU PHE SER LEU ARG ILE GLN GLU PHE ILE GLU LEU SEQRES 17 i 396 ILE ARG GLN ASN LYS ARG LEU ASP ALA VAL ARG HIS ALA SEQRES 18 i 396 ARG LYS HIS PHE SER GLN ALA GLU GLY SER GLN LEU ASP SEQRES 19 i 396 GLU VAL ARG GLN ALA MET GLY MET LEU ALA PHE PRO PRO SEQRES 20 i 396 ASP THR HIS ILE SER PRO TYR LYS ASP LEU LEU ASP PRO SEQRES 21 i 396 ALA ARG TRP ARG MET LEU ILE GLN GLN PHE ARG TYR ASP SEQRES 22 i 396 ASN TYR ARG LEU HIS GLN LEU GLY ASN ASN SER VAL PHE SEQRES 23 i 396 THR LEU THR LEU GLN ALA GLY LEU SER ALA ILE LYS THR SEQRES 24 i 396 PRO GLN CYS TYR LYS GLU ASP GLY SER SER LYS SER PRO SEQRES 25 i 396 ASP CYS PRO VAL CYS SER ARG SER LEU ASN LYS LEU ALA SEQRES 26 i 396 GLN PRO LEU PRO MET ALA HIS CYS ALA ASN SER ARG LEU SEQRES 27 i 396 VAL CYS LYS ILE SER GLY ASP VAL MET ASN GLU ASN ASN SEQRES 28 i 396 PRO PRO MET MET LEU PRO ASN GLY TYR VAL TYR GLY TYR SEQRES 29 i 396 ASN SER LEU LEU SER ILE ARG GLN ASP ASP LYS VAL VAL SEQRES 30 i 396 CYS PRO ARG THR LYS GLU VAL PHE HIS PHE SER GLN ALA SEQRES 31 i 396 GLU LYS VAL TYR ILE MET SEQRES 1 u 76 MET GLN ILE PHE VAL LYS THR LEU THR GLY LYS THR ILE SEQRES 2 u 76 THR LEU GLU VAL GLU PRO SER ASP THR ILE GLU ASN VAL SEQRES 3 u 76 LYS ALA LYS ILE GLN ASP LYS GLU GLY ILE PRO PRO ASP SEQRES 4 u 76 GLN GLN ARG LEU ILE PHE ALA GLY LYS GLN LEU GLU ASP SEQRES 5 u 76 GLY ARG THR LEU SER ASP TYR ASN ILE GLN LYS GLU SER SEQRES 6 u 76 THR LEU HIS LEU VAL LEU ARG LEU ARG GLY GLY MODRES 8PJN SEP 2 164 SER MODIFIED RESIDUE MODRES 8PJN SEP 2 165 SER MODIFIED RESIDUE MODRES 8PJN SEP 2 166 SER MODIFIED RESIDUE MODRES 8PJN SEP 2 168 SER MODIFIED RESIDUE MODRES 8PJN SEP 2 169 SER MODIFIED RESIDUE MODRES 8PJN SEP 2 171 SER MODIFIED RESIDUE MODRES 8PJN SEP 2 174 SER MODIFIED RESIDUE HET SEP 2 164 10 HET SEP 2 165 10 HET SEP 2 166 10 HET SEP 2 168 10 HET SEP 2 169 10 HET SEP 2 171 10 HET SEP 2 174 10 HET ZN b 501 1 HET ZN i 401 1 HETNAM SEP PHOSPHOSERINE HETNAM ZN ZINC ION HETSYN SEP PHOSPHONOSERINE FORMUL 2 SEP 7(C3 H8 N O6 P) FORMUL 5 ZN 2(ZN 2+) HELIX 1 1 ASP b 2 LYS b 40 1 39 HELIX 2 2 SER b 58 ASP b 81 1 24 HELIX 3 3 HIS b 83 ASN b 96 1 14 HELIX 4 4 SER b 114 ARG b 128 1 15 HELIX 5 5 LEU b 132 GLN b 140 1 9 HELIX 6 6 SER b 149 ALA b 163 1 15 HELIX 7 7 ILE b 262 LEU b 273 1 12 HELIX 8 8 PRO b 281 GLN b 305 1 25 HELIX 9 9 ARG b 360 LYS b 365 1 6 HELIX 10 1 LYS 2 8 GLU 2 20 1 13 HELIX 11 2 VAL 2 90 TRP 2 95 5 6 HELIX 12 3 LEU 2 101 ALA 2 114 1 14 HELIX 13 4 GLY 2 124 HIS 2 132 1 9 HELIX 14 5 PRO 2 134 TYR 2 148 1 15 HELIX 15 1 ALA i 7 GLN i 17 1 11 HELIX 16 2 TYR i 19 SER i 59 1 41 HELIX 17 3 VAL i 64 HIS i 109 1 46 HELIX 18 4 ALA i 116 CYS i 136 1 21 HELIX 19 5 TYR i 139 SER i 149 1 11 HELIX 20 6 ILE i 157 GLU i 171 1 15 HELIX 21 7 ALA i 176 ASP i 184 1 9 HELIX 22 8 LYS i 186 LYS i 191 1 6 HELIX 23 9 LEU i 196 ARG i 210 1 15 HELIX 24 10 ARG i 214 HIS i 224 1 11 HELIX 25 11 SER i 231 ALA i 244 1 14 HELIX 26 12 TYR i 254 LEU i 258 1 5 HELIX 27 13 ARG i 262 LEU i 277 1 16 HELIX 28 14 VAL i 285 ILE i 297 1 13 HELIX 29 15 PRO i 300 TYR i 303 1 4 HELIX 30 16 ARG i 319 LEU i 324 1 6 HELIX 31 17 TYR i 364 ILE i 370 1 7 HELIX 32 1 ILE u 23 GLU u 34 1 12 HELIX 33 2 LEU u 56 ASN u 60 1 5 SHEET 1 AA1 4 GLU 2 24 ILE 2 27 0 SHEET 2 AA1 4 GLU 2 33 GLY 2 40 -1 O VAL 2 35 N THR 2 26 SHEET 3 AA1 4 GLY 2 49 ASP 2 56 -1 N VAL 2 55 O PHE 2 34 SHEET 4 AA1 4 SER 2 67 PHE 2 70 -1 O GLY 2 69 N ARG 2 54 SHEET 1 AA2 6 GLU i 391 TYR i 394 0 SHEET 2 AA2 6 PRO i 353 MET i 355 -1 O PRO i 353 N VAL i 393 SHEET 3 AA2 6 GLY i 359 TYR i 362 -1 O TYR i 360 N LEU i 356 SHEET 4 AA2 6 GLN b 388 PHE b 391 1 O PHE b 390 N VAL i 361 SHEET 5 AA2 6 PRO b 349 LYS b 351 -1 O PRO b 349 N ILE b 389 SHEET 6 AA2 6 ILE b 357 SER b 359 -1 O ILE b 358 N MET b 350 SHEET 1 AA3 2 SER b 370 LYS b 373 0 SHEET 2 AA3 2 MET b 379 SER b 382 -1 O GLN b 381 N LEU b 372 SHEET 1 AA4 4 THR u 12 GLU u 16 0 SHEET 2 AA4 4 GLN u 2 THR u 7 -1 O ILE u 3 N LEU u 15 SHEET 3 AA4 4 THR u 66 LEU u 71 1 O LEU u 67 N LYS u 6 SHEET 4 AA4 4 GLN u 41 ILE u 44 -1 O ILE u 44 N HIS u 68 LINK C SEP 2 164 N SEP 2 165 1555 1555 1.34 LINK C SEP 2 165 N SEP 2 166 1555 1555 1.34 LINK C SEP 2 166 N GLU 2 167 1555 1555 1.33 LINK C GLU 2 167 N SEP 2 168 1555 1555 1.34 LINK C SEP 2 168 N SEP 2 169 1555 1555 1.33 LINK C SEP 2 169 N MET 2 170 1555 1555 1.33 LINK C MET 2 170 N SEP 2 171 1555 1555 1.34 LINK C SEP 2 171 N ASP 2 172 1555 1555 1.34 LINK C PHE 2 173 N SEP 2 174 1555 1555 1.34 LINK C SEP 2 174 N GLU 2 175 1555 1555 1.33 LINK NE2 HIS b 331 ZN ZN i 401 1555 1555 2.03 LINK SG CYS b 354 ZN ZN b 501 1555 1555 2.31 LINK ND1 HIS b 356 ZN ZN b 501 1555 1555 2.03 LINK SG CYS b 374 ZN ZN b 501 1555 1555 2.31 LINK SG CYS b 377 ZN ZN b 501 1555 1555 2.31 LINK SG CYS i 302 ZN ZN i 401 1555 1555 2.31 LINK SG CYS i 314 ZN ZN i 401 1555 1555 2.31 LINK SG CYS i 317 ZN ZN i 401 1555 1555 2.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000